Health Innovation Roundup
The Health Innovation Roundup provides you with the latest headlines and happenings related to health innovation in the Edmonton region.
Recent editions
Wednesday, January 19, 2022
The latest headlines & happenings in health innovation in Edmonton. AltaML has formed a strategic alliance with Amplitude Venture Capital, a top Canadian firm focused on life sciences and building precision medicine companies. The partnership will look to leverage the possibility of artificial intelligence and machine learning in the biotechnology sector.
Read this editionWednesday, January 12, 2022
The latest headlines & happenings in health innovation in Edmonton. Edmonton-based Entos Pharmaceuticals has signed an agreement with Eli Lilly, giving the American pharmaceutical company exclusive rights to Entos's Fusogenix PLV technology for $50 million now and up to $400 million in the future.
Read this editionWednesday, January 5, 2022
The latest headlines & happenings in health innovation in Edmonton. Health innovators and entrepreneurs across Alberta have two more weeks to apply for the inaugural Startup TNT Life Sciences Investment Summit in March. Startup TNT has partnered with Applied Pharmaceutical Innovation (API) to organize the event, which will be the province's largest investment summit focused on life sciences — with a goal of investing over $1 million into participating seed-stage companies.
Read this editionRecent articles
A look at health innovation in Edmonton during 2021
As Alberta's health innovation industry grows, Edmonton companies continue to demonstrate their ability to be leaders in areas like drug and vaccine development and biotechnology infrastructure.
Continue reading
Entos Pharmaceuticals secures partial funding for commercial manufacturing facility in Edmonton
The provincial government has committed $15.5 million in funding to Entos Pharmaceuticals to establish a new commercial manufacturing facility in Edmonton, which would produce vaccines as well as future genetic medicines. Now it's "a dance" to secure the rest of the funding needed.
Continue reading
AltaML and PROTXX make headway on concussion diagnostics
A partnership between precision health-care technology company PROTXX and Edmonton-based AltaML has resulted in a new benchmark in concussion diagnostics, the results of which were recently published in the journal Sensors.
Continue reading
Sponsors
Thank to you to our Cultivator sponsors for helping to make our work possible:
